Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation (WU-KONG1)

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

July 9, 2019

Primary Completion Date

July 29, 2024

Study Completion Date

July 31, 2025

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Sunvozertinib

Daily dose of Sunvozertinib

Trial Locations (124)

10016

Laura and Isaac Perlmutter Cancer Center, New York

10029

Icahn School of Medicine at Mount Sinai, New York

22031

Virginia Cancer Specialists, Fairfax

33612

H. Lee Moffitt Cancer Center & Research Institute, Tampa

48334

Michigan Center of Medical Research, Farmington Hills

80045

University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora

92093

University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla

92868

University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center, Orange

90603-2137

Innovative Clinical Research Institute, LLC, Whittier

02215

Dana-Farber Cancer Institute, Boston

11042-1118

Northwell Health - Centers for Advanced Medicine, New Hyde Park

43210-1240

The Ohio State University Comprehensive Cancer Center, Columbus

Unknown

Fundacion Respirar - Consultorios Medicos Dr. Doreski, Cabildo

CEMIC Centro de Educación Médica e Investigaciones Clínicas - Hospital Universitario sede Saavedra, Ciudad Autónoma Buenos Aires

Centro Medico Austral OMI, Ciudad Autónoma Buenos Aires

Diabaid, Ciudad Autónoma Buenos Aires

Fundacion CENIT Para La Investigacion en Neurociencias, Ciudad Autónoma Buenos Aires

Instituto Argentino de Diagnositco y Tratamiento S.A., Ciudad Autónoma Buenos Aires

Instituto Medico de la Fundacion de Estudios Clínicos, Ciudad Autónoma Buenos Aires

Centro de Investigación Pergamino SA, Pergamino

Clinica Viedma S.A, Viedma

Blacktown Hospital, Blacktown

Chris O'Brien Lifehouse, Camperdown

Austin Hospital, Heidelberg

St George Hospital, Kogarah

Peter MacCallum Cancer Centre - East Melbourne, North Melbourne

Linear Cancer trials, Perth

Southern Medical Day Care Centre, Wollongong

Princess Margaret Cancer Centre, Toronto

Fundación Arturo López Pérez, Providencia

Orlandi Oncología - Centro Médico Health & Care, Santiago

SAGA, Santiago

James Lind Centro De Investigacion Del Cancer, Temuco

Beijing Cancer Hospital, Beijing

Beijing Chest Hospital,Capital Medical University, Beijing

Peking Union Medical College Hospital, Beijing

Jilin Cancer Hospital, Changchun

Hunan Cancer Hospital, Changsha

West China Hospital of Sichuan University, Chengdu

Chongqing Cancer Hospital, Chongqing

Fujian Cancer Hospital, Fuzhou

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Hainan General Hospital, Haikou

The First Affilated Hospital of Zhejiang University, Hangzhou

Zhejiang Cancer Hospital, Hangzhou

Harbin Medical University Cancer Hospital, Harbin

The first Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei

The Second Hospital of Anhui Medical University, Hefei

Henan Cancer Hospital, Henan

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

The Affiliated Huaian No.1 Peoples Hospital of Nanjing Medical University, Huai'an

Jinan Central Hospital, Jinan

Linyi Cancer Hospital, Linyi

The First Affiliated Hospital of Nanchang University, Nanchang

The Second Affiliated Hospital of Nanchang University, Nanchang

Guangxi Medical University Cancer Hospital, Nanning

Zhongshan Hospital, Fudan University, Shanghai

The First Hospital of China Medical University, Shenyang

Shanxi Cancer Hospital, Taiyuan

Taizhou Hospital of Zhejiang Province, Taizhou

Tianjin Medical University Cancer Institute & Hospital, Tianjin

Hubei Cancer Hospital, Wuhan

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Centre Hospitalier Universitaire d'Angers, Angers

Hospices Civils de Lyon - Hôpital Louis Pradel, Bron

Centre Georges François Leclerc, Dijon

CHU de Lille - Institut Coeur Poumons, Hellemmes-Lille

Hôpital de La Timone AP-Hm, Marseille

CHU de Montpellier Hôpital Arnaud de Villeneuve, Montpellier

APHP-Hôpital Bichat - Claude Bernard, Paris

CHU de Poitiers, Poitiers

Institut de Cancérologie de l'Ouest, Saint-Herblain

HIA Begin, Saint-Mandé

CHU de Toulouse - Hôpital Larrey, Toulouse

Institut Gustave ROUSSY, Villejuif

Centro di Riferimento Oncologico (CRO), Aviano

"Azienda Ospedaliero - Universitaria Policlinico - Vittorio Emanuele", Catania

Azienda Ospedaliero-Universitaria Careggi, Florence

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST IRCCS, Meldola

Istituto Europeo di Oncologia, Milan

Azienda Ospedaliero-Universitaria di Parma, Parma

AUSL Romagna - Ospedale S.M delle Croci, Ravenna

Arcispedale Santa Maria Nuova, Reggio Emilia

Istituti Fisioterapici Ospitalieri, Roma

National Hospital Organization Shikoku Cancer Center, Matsuyama

Aichi Cancer Center Hospital, Nagoya

Niigata University Medical & Dental Hospital, Niigata

Okayama University Hospital, Okayama

Tokushima University Hospital, Tokushima

Tokyo Shinagawa Hospital, Tokyo

Hospital Sultan Ismail, Johor Bahru

Hospital Kuala Lumpur, Kuala Lumpur

University Malaya Medical Centre, Kuala Lumpur

Chungbuk National University Hospital, Cheonju

National Cancer Center, Goyang

Seoul National University Bundang Hospital, Seongnam

Asan Medical Center, Seoul

Seoul National University Hospital, Seoul

The Catholic University of Korea, St. Vincent's Hospital, Suwon

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Universitari Vall d'Hebrón, Barcelona

ICO (Institut Catala d'Oncologia) Badalona - Hospital Germans Trias i Pujol, Barcelona

Institut Català d'Oncología de Girona - Hospital Universitari de Girona Dr. Josep Trueta, Girona

Hospital de Jeréz, Jerez de la Frontera

Centro Integral Oncológico Clara Campal (CIOCC), Madrid

Clínica Universidad de Navarra, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario Fundacion Jimenez Diaz, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Regional Universitario de Malaga, Málaga

Hospital Universitario Virgen de Valme, Seville

Hospital Universitario Virgen Macarena, Seville

Hospital La Fe, Valencia

Chi Mei Hospital, Liouying, Liuying

Taichung Veterans General Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Wan Fang Hospital, Taipei

Chang Gung Memorial Hospital, Taoyuan District

Sponsors
All Listed Sponsors
lead

Dizal Pharmaceuticals

INDUSTRY

NCT03974022 - Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation (WU-KONG1) | Biotech Hunter | Biotech Hunter